Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways

Clinical success of chimeric antigen receptor (CAR) T cell immunotherapy requires the engineering of autologous T cells, which limits the broader implementation of CAR cell therapy. The development of allogeneic and universal cell products will significantly broaden their application and reduce cost...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Methods Clin Dev
Main Authors: Yang, Yan, Badeti, Saiaditya, Tseng, Hsiang-chi, Ma, Minh Tuyet, Liu, Ting, Jiang, Jie-Gen, Liu, Chen, Liu, Dongfang
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364029/
https://ncbi.nlm.nih.gov/pubmed/32695845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.06.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados